Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on PAG. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel BCl3 catalyzed route improves yield and safety for SGLT2 inhibitor manufacturing supply chain reliability and cost efficiency significantly for global buyers.
This novel cation exchange resin method reduces wastewater and improves purity for Empagliflozin manufacturing supply chain reliability and operational efficiency significantly.
Novel stable process for Empagliflozin manufacturing. Reduces impurities, ensures supply continuity, and offers cost-effective commercial scale-up for global pharmaceutical partners.
Patent CN118005766B reveals novel solid-phase synthesis for Glepaglutide improving purity and yield. Discover cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN109384720B details a novel route for high-purity photoacid generators, solving hydrolysis issues and ensuring supply chain stability for electronic chemical manufacturing.
Novel patent CN119552143A details high-yield dapagliflozin intermediate synthesis. Reduces impurities and enhances supply chain reliability for global pharmaceutical manufacturing partners.
Novel nickel-catalyzed synthesis offers high yield and stereoselectivity for SGLT-2 inhibitors. Ensures supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel 3-step synthesis for Dapagliflozin ensures high yield and purity. Cost-effective manufacturing solution for global pharmaceutical supply chains.
Novel one-pot method for (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone. High purity, reduced steps, eco-friendly process for API manufacturing.
Novel synthetic route for IMPD reference standard offering higher yield and safer conditions for pharmaceutical quality control supply chains globally.
Patent CN102786498A details a novel Repaglinide synthesis using CDI coupling and optimized deprotection, offering significant cost reduction and scalability for API manufacturing.
Patent CN101982453B reveals a microwave-assisted ionic liquid method for high-yield paraben production, offering significant supply chain and cost advantages.
Patent CN109111490B introduces a novel halogenated pivaloyl glucopyranose route for SGLT2 inhibitors, offering superior stereoselectivity and industrial scalability for pharmaceutical manufacturing.
Novel three-step method enhances purity and yield for Dapagliflozin manufacturing, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1571769A details a cost-effective mixed anhydride method for repaglinide, offering significant supply chain advantages and high-purity manufacturing capabilities.
Analysis of CN100445275C reveals a high-yield acyl chloride route for repaglinide. Discover cost-effective manufacturing strategies and supply chain advantages for this key antidiabetic API intermediate.
Novel InBr3-catalyzed route for empagliflozin key intermediate offers high purity and industrial scalability for pharma supply chains.
Advanced synthetic route for Dapagliflozin isomer impurities ensuring high purity. Optimized for pharmaceutical quality research and reliable supply chain integration.
Advanced synthesis of Repaglinide intermediates via DEPBT coupling. Delivers high optical purity and cost reduction in API manufacturing for global supply chains.
Novel fragment condensation method for Gelpaglutide improves crude purity to over 75 percent and total yield to nearly 30 percent, offering significant cost reduction in polypeptide manufacturing.